BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 20081177)

  • 1. Efficacy of combined porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae vaccination in piglets.
    Drexler CS; Witvliet MH; Raes M; van de Laar M; Eggen AA; Thacker EL
    Vet Rec; 2010 Jan; 166(3):70-4. PubMed ID: 20081177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between single-dose Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus vaccines on dually infected pigs.
    Park SJ; Seo HW; Park C; Chae C
    Res Vet Sci; 2014 Jun; 96(3):516-22. PubMed ID: 24702900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge.
    Oh T; Park KH; Yang S; Jeong J; Kang I; Park C; Chae C
    BMC Vet Res; 2019 Oct; 15(1):342. PubMed ID: 31619295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Mycoplasma hyopneumoniae vaccine on pigs naturally infected with M. hyopneumoniae and porcine reproductive and respiratory syndrome virus.
    Moreau IA; Miller GY; Bahnson PB
    Vaccine; 2004 Jun; 22(17-18):2328-33. PubMed ID: 15149792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 3 vaccination strategies against porcine reproductive and respiratory syndrome virus,
    Jeong J; Kang I; Kim S; Park KH; Park C; Chae C
    Can J Vet Res; 2018 Jan; 82(1):39-47. PubMed ID: 29382967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vaccination on the potentiation of porcine reproductive and respiratory syndrome virus (PRRSV)-induced pneumonia by Mycoplasma hyopneumoniae.
    Thacker EL; Thacker BJ; Young TF; Halbur PG
    Vaccine; 2000 Jan; 18(13):1244-52. PubMed ID: 10649626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal vaccination strategy against Mycoplasma hyopneumoniae, porcine reproductive and respiratory syndrome virus, and porcine circovirus type 2 in case of early M. hyopneumoniae infection.
    Yang S; Oh T; Mago J; Iwakuma A; Chae C
    Vet Med Sci; 2020 Nov; 6(4):860-874. PubMed ID: 32462794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combined vaccination against Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus in dually infected pigs.
    Bourry O; Fablet C; Simon G; Marois-Créhan C
    Vet Microbiol; 2015 Nov; 180(3-4):230-6. PubMed ID: 26422712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 2 commercial single-dose Mycoplasma hyopneumoniae vaccines and porcine reproductive and respiratory syndrome virus (PRRSV) vaccines on pigs dually infected with M. hyopneumoniae and PRRSV.
    Park C; Kang I; Seo HW; Jeong J; Choi K; Chae C
    Can J Vet Res; 2016 Apr; 80(2):112-23. PubMed ID: 27127338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcine respiratory disease complex: Interaction of vaccination and porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, and Mycoplasma hyopneumoniae.
    Chae C
    Vet J; 2016 Jun; 212():1-6. PubMed ID: 27256017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified live PRRSV vaccine and the pathogenic parent strain induce regulatory T cells in pigs naturally infected with Mycoplasma hyopneumoniae.
    LeRoith T; Hammond S; Todd SM; Ni Y; Cecere T; Pelzer KD
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):312-6. PubMed ID: 21272944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a production region model to assess the efficacy of various air filtration systems for preventing airborne transmission of porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae: results from a 2-year study.
    Dee S; Otake S; Deen J
    Virus Res; 2010 Dec; 154(1-2):177-84. PubMed ID: 20667494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV.
    Scortti M; Prieto C; Alvarez E; Simarro I; Castro JM
    Vet Rec; 2007 Dec; 161(24):809-13. PubMed ID: 18083979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses induced in mice immunized with recombinant adenovectors expressing chimeric proteins of various porcine pathogens.
    Roques E; Girard A; Gagnon CA; Archambault D
    Vaccine; 2013 May; 31(24):2698-704. PubMed ID: 23583895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased production of proinflammatory cytokines following infection with porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae.
    Thanawongnuwech R; Thacker B; Halbur P; Thacker EL
    Clin Diagn Lab Immunol; 2004 Sep; 11(5):901-8. PubMed ID: 15358650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmid-mediated growth hormone-releasing hormone efficacy in reducing disease associated with Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus infection.
    Thacker EL; Holtkamp DJ; Khan AS; Brown PA; Draghia-Akli R
    J Anim Sci; 2006 Mar; 84(3):733-42. PubMed ID: 16478966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus.
    Jiang Y; Fang L; Xiao S; Zhang H; Pan Y; Luo R; Li B; Chen H
    Vaccine; 2007 Jan; 25(3):547-60. PubMed ID: 16920232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2.
    Kim D; Kim CH; Han K; Seo HW; Oh Y; Park C; Kang I; Chae C
    Vaccine; 2011 Apr; 29(17):3206-12. PubMed ID: 21354247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.